Naproxen CAS 22204-53-1 Kuchena > 99.5% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. ndiyo inotungamira mugadziri uye mutengesi weNaproxen (CAS: 22204-53-1) ine mhando yepamusoro.Isu tinogona kupa COA, kuendesa pasi rese, zvidiki uye huwandu hwakawanda huripo.Kana iwe uchifarira chigadzirwa ichi, ndapota tumira ruzivo rwakadzama runosanganisira nhamba yeCAS, zita rechigadzirwa, huwandu kwatiri.Please contact: alvin@ruifuchem.com
Chemical Name | (S)-(+)-2-(6-Methoxy-2-Naphthyl)propionic Acid |
Mashoko anoreva zvakafanana | Naproxen;(S)-Naproxen;(S)-(+)-Naproxene;(S)-(+)-6-Methoxy-α-Methyl-2-Naphthaleneacetic Acid;(+)-6-Methoxy-alpha-Methyl-2-Naphthaleneacetic Acid |
Nhamba yeCAS | 22204-53-1 |
Nhamba yeCAT | RF2890 |
Stock Status | MuStock, ProductionProduction Capacity 1000 Matani pagore |
Molecular Formula | C14H14O3 |
Molecular Weight | 230.26 |
Melting Point | 154.0 ~ 158.0℃ |
Kuchengeta & Sensitivity | Chiedza Sensitive.Ambient Temperature |
Solubility | Inoita Insoluble muMvura.Soluble muEthanol (96%) uye muMethanol |
Hazard Kirasi | 6.1(b) |
Packing Group | III |
HS Code | 29189900 |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | Ichena kusvika kuOff-White Crystalline Powder |
Kuchena / Analysis Method | >99.0% (HPLC) |
Kuchena / Analysis Method | > 99.0% (Neutralization Titration) |
Melting Point | 154.0 ~ 158.0℃ |
Kutenderera kwakananga [α]20/D | +83.0 ° kusvika +89.5 ° |
Kurasika paKuomesa | <0.50% |
Residue paIgnition | <0.20% |
Heavy Metals | <0.002% |
Related Substances | |
Kusachena Kumwechete | <0.50% |
Zvose Zvisina Kuchena | <1.00% |
Infrared Spectrum | Inopindirana neChimiro |
Test Standard | Enterprise Standard |
Usage | Active Pharmaceutical Ingredients (API) & Intermediates |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma.Dzivirira kubva kuchiedza uye unyoro.Hazvienderani neakasimba oxidizing agents.
Kutenga sei?Please contactDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
Makore 15 Oupenyu?Tine makore anopfuura 15 ane ruzivo mukugadzira uye kutumira kunze kwemhando dzakasiyana-siyana dzepamusoro dzemishonga yepakati kana makemikari akanaka.
Main Markets?Tengesa kumusika wepamba, North America, Europe, India, Korea, Japan, Australia, nezvimwe.
Zvakanakira?Hunhu hwepamusoro, mutengo unokwanisika, masevhisi ehunyanzvi uye rutsigiro rwehunyanzvi, kuendesa nekukurumidza.
HunhuSimbiso?Strict quality control system.Midziyo yehunyanzvi yekuongorora inosanganisira NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, nezvimwe.
Samples?Zvigadzirwa zvakawanda zvinopa mahara emahara ekuongorora kwemhando, mutengo wekutumira unofanirwa kubhadharwa nevatengi.
Factory Audit?Factory audit inogamuchirwa.Ndapota itai nguva isati yasvika.
MOQ?Hapana MOQ.Kurongeka kudiki kunogamuchirwa.
Delivery Nguva? Kana mukati me stock, mazuva matatu kutumirwa anovimbiswa.
Transportation?Ne Express (FedEx, DHL), neMhepo, neGungwa.
Zvinyorwa?Mushure mekutengesa sevhisi: COA, MOA, ROS, MSDS, nezvimwe zvinogona kupihwa.
Custom Synthesis?Inogona kupa echinyakare synthesis masevhisi kuti aenderane nezvinodiwa zvako zvekutsvagisa.
Payment Terms?Proforma invoice inozotumirwa kutanga mushure mekusimbisa kurongeka, yakavharirwa ruzivo rwedu rwebhangi.Kubhadhara neT/T (Telex Transfer), PayPal, Western Union, nezvimwe.
Naproxen (CAS: 22204-53-1) isiri-steroidal anti-inflammatory drug, iri PG synthase inhibitor, inogona kudzivisa prostaglandin synthetase, ine zvakakosha analgesic uye antipyretic madhara, kunwa kwemuromo kunokurumidza uye kwakakwana, 2 kusvika. Maawa 4 mushure memushonga, kusungirirwa kweplasma kunosvika pakakwirira, muropa, inopfuura 99% inosungirirwa kumapuroteni eplasma, t1/2 maawa 13 kusvika ku14, inenge 95% inobudiswa muweti neprototype uye metabolites.Inoshandiswa kuchipatara Kurapa rheumatic uye rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gout, arthritis, tenosynovitis.inogonawo kushandiswa kuderedza marwadzo anokonzerwa ne musculoskeletal sprains, contusions, kukuvara uye dysmenorrhea.Asi zvinofanirwa kucherechedzwa kuti semamwe ma-non-steroidal anti-inflammatory drugs, iwoyo akakomba gastrointestinal adverse reactions anogona kuitika chero nguva uchitora naproxen panguva yekurapa, saka vanoshingaira gastroduodenal ulcer varwere vanoturikwa, mamwe egastroduodenal turakiti chirwere varwere vanofanira kutora izvi. mushonga uri pasi pekutariswa kwechiremba.Naproxen inogadzirwa kubva ku2-methoxynaphthalene uye iyo (+)-isomeri inowanikwa nekugadziriswa ne cinchonidine (61).Yakatangwa muUnited States muna 1976 uye, semushonga wegeneric, yakagara iri pakati peNSAID dzinozivikanwa zvikuru.Inotengeswa seS-(+) -enantiomer, asi zvinonakidza, munyu wesodium we (-) -isomer uri pamusika seAnaprox.Se inhibitor ye prostaglandin biosynthesis, ine simba rakapetwa ka12 pane aspirin, ine simba rakapetwa ka10 pane phenylbutazone, katatu kana kana ine simba kupfuura ibuprofen, uye kakapetwa kana ine simba kupfuura fenoprofen, asi ine simba rakapetwa ka300 pane indomethacin.